CHIANG KYLE (Chief Operating Officer) sold 11.3% of their position (2.98K shares) of LOGICBIO THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/19/2021ACC: 0001209191-21-027460
Officer· Chief Operating Officer
Since Nov 2020
-2.98K
Net shares
Net seller
$17.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.36K acquired · 12.34K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.36K
Price / share
—
Trade value
—
% of position
55.0%
4/15/2021
17K→26.36K
Common Stock
Direct
Shares
−2.98K
Price / share
$5.73
Trade value
$17.06K
% of position
11.3%
4/16/2021
26.36K→23.39K
Total
Net shares
+6.38K
Net value
-$17.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2021 | M · Option Exercise | +9.36K | — | — | 55.0% | 17K | 26.36K |
| Common Stock Direct | 4/16/2021 | S · Sale | −2.98K | $5.73 | $17.06K | 11.3% | 26.36K | 23.39K |
| Total | +6.38K | -$17.06K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
9.36K shares
Shares
−9.36K
Strike price
Held after
0.00
Exercisable
—
4/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock9.36K shares | 4/15/2021 | M · Option Exercise | −9.36K | — | 0.00 |